These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 9747960

  • 21. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME, Kontto JP, Virtamo J, Hätönen KA, Valsta LM, Sundvall J, Männistö S.
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [Abstract] [Full Text] [Related]

  • 22. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 23. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
    Shishko PI, Dreval AV, Abugova IA, Zajarny IU, Goncharov VC.
    Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
    [Abstract] [Full Text] [Related]

  • 24. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K.
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [Abstract] [Full Text] [Related]

  • 25. Protein glycation: its role in the changes induced by diabetes in the properties of the serum insulin-like growth factor-I binding proteins.
    Cortizo AM, Gagliardino JJ.
    J Endocrinol; 1991 Oct; 131(1):33-8. PubMed ID: 1720805
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 27. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT, Barrios V, Pozo J, Argente J.
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
    Falorni A, Bini V, Cabiati G, Papi F, Arzano S, Celi F, Sanasi M.
    Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
    [Abstract] [Full Text] [Related]

  • 29. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A, Lang CH, Blethen SL, Ng LC, Wilson TA.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [Abstract] [Full Text] [Related]

  • 30. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [Abstract] [Full Text] [Related]

  • 31. Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetes.
    Khamaisi M, Flyvbjerg A, Haramati Z, Raz G, Wexler ID, Raz I.
    Int J Exp Diabetes Res; 2002 Jul; 3(4):257-64. PubMed ID: 12546279
    [Abstract] [Full Text] [Related]

  • 32. The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial.
    Zandbergen AA, Lamberts SW, Baggen MG, Janssen JA, Boersma E, Bootsma AH.
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):203-8. PubMed ID: 16430721
    [Abstract] [Full Text] [Related]

  • 33. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 34. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P.
    Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
    [Abstract] [Full Text] [Related]

  • 35. The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus.
    NeamŢu MC, Avramescu ET, Marcu IR, Turcu-Ştiolică A, Boldeanu MV, NeamŢu OM, Tudorache Ş, Dănciulescu Miulescu RE.
    Rom J Morphol Embryol; 2017 Apr; 58(3):857-861. PubMed ID: 29250665
    [Abstract] [Full Text] [Related]

  • 36. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P, Bayón C, Méndez J, Gancedo PG, Grande C, Diez JJ.
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [Abstract] [Full Text] [Related]

  • 37. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
    Thierry van Dessel HJ, Chandrasekher Y, Yap OW, Lee PD, Hintz RL, Faessen GH, Braat DD, Fauser BC, Giudice LC.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
    [Abstract] [Full Text] [Related]

  • 38. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F.
    Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636
    [Abstract] [Full Text] [Related]

  • 39. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A, Brismar K, Degerblad M, Thorén M, Hall K.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.